Timothy R. Cote - 03 May 2023 Form 3 Insider Report for SOLIGENIX, INC. (SNGX)

Role
Director
Signature
/s/ Timothy R. Cote
Issuer symbol
SNGX
Transactions as of
03 May 2023
Net transactions value
$0
Form type
3
Filing time
05 May 2023, 18:25:54 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SNGX Common Stock 25,317 03 May 2023 Silk Road Therapeutics, Inc. F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported units for purposes of Section 16 or for any other purpose.